Home
Archive
Subscribe
The Renewal
Logo

Clinical trial literacy


The donor cells that can't be killed by the drug

The donor cells that can't be killed by the drug

The donor cells survived the drug that was supposed to destroy them. What happened to the cancer is what this issue explains.

May 30, 2026

•

6 min read

Twenty years. Seven patients. A conditional approval.

Twenty years. Seven patients. A conditional approval.

In March, Japan approved the world's first iPSC-derived therapies. Here is what the evidence behind that approval actually looks like.

May 7, 2026

•

6 min read

What happens after the FDA says yes

What happens after the FDA says yes

The clinical trial worked. The FDA approved it. The patients who need it most are still waiting.

Apr 30, 2026

•

5 min read

They treated a fetus with stem cells

They treated a fetus with stem cells

The result was specific, limited, and more important than most headlines made it sound.

Apr 7, 2026

•

8 min read

background

The Renewal

Real regenerative medicine news, explained honestly, in ten minutes a week.

NAVIGATE

STAY INFORMED

Join readers who want the truth about regenerative medicine.

© 2026 The Renewal.
beehiivPowered by beehiiv